Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis
2022 · JACC. Cardiovascular imaging · 44 citations
https://doi.org/10.1016/j.jcmg.2022.06.004
Y
Yubo Guo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
183
Citations
8
h-index
6
i10-index
Yubo Guo is an academic researcher from Capital Medical University. The author has contributed to research in topics: Cardiac Imaging and Diagnostics & Amyloidosis: Diagnosis, Treatment, Outcomes & Advanced MRI Techniques and Applications. The author has an h-index of 8, co-authored 25 publications.
ORCID: 0009-0009-7632-2667Papers by this author
worksDiagnostic Improvements of Deep Learning–Based Image Reconstruction for Assessing Calcification-Related Obstructive Coronary Artery Disease
2021 · Frontiers in Cardiovascular Medicine · 22 citations
https://doi.org/10.3389/fcvm.2021.758793
Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision
2025 · JACC. Cardiovascular imaging · 10 citations
https://doi.org/10.1016/j.jcmg.2024.10.001
Comprehensive prognosis assessment of cardiovascular magnetic resonance parametric mapping in light chain amyloidosis
2024 · Journal of Cardiovascular Magnetic Resonance · 3 citations
https://doi.org/10.1016/j.jocmr.2024.101135
Myocardial native T1 and extracellular volume measurements at 5T: Feasibility study and initial experience
2025 · Journal of Cardiovascular Magnetic Resonance · 3 citations
https://doi.org/10.1016/j.jocmr.2025.101896
Identification of Myocardial Scarring Using <scp>Contrast‐Free</scp> Cardiac <scp>MRI</scp> in Patients With Autoimmune Rheumatic Diseases
2023 · Journal of Magnetic Resonance Imaging · 2 citations
https://doi.org/10.1002/jmri.29130
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat